TAYLOR HOLSOMBECK: Open Payments
NPI 1013600923 · HOMEWOOD, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,207 in 64 payments from 16 companies in 2025. Trend: 2023 $462 · 2024 $1,044 · 2025 $1,207
Food & beverage: $1,207
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 13 | $261 |
| Organon LLC | 9 | $219 |
| ABBVIE INC. | 12 | $138 |
| MAYNE PHARMA COMMERCIAL LLC | 5 | $103 |
| Arcutis Biotherapeutics, Inc. | 4 | $73 |
| Lilly USA, LLC | 3 | $69 |
| Galderma Laboratories, L.P. | 4 | $65 |
| Incyte Corporation | 3 | $47 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $44 |
| Botanix SB Inc | 2 | $38 |
Products named: VTAMA, COSENTYX, SKYRIZI, Zoryve, EBGLYSS, NEMLUVIO, RINVOQ, OPZELURA.
Industry payments across AL — which companies pay providers there.
